Search Orphan Drug Designations and Approvals
-
| Generic Name: | Allogenic Chimeric Antigen Receptor T Cells Targeting B Cell Maturation Antigen (BCMA) |
|---|---|
| Date Designated: | 08/10/2021 |
| Orphan Designation: | Treatment of Multiple Myeloma |
| Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Allogene Therapeutics 210 E Grand Ave South San Francisco, California 94080 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







